TSE:5290 stock news
This page provides real-time market news, earnings updates, and company announcements related to Vertex Corp. (TSE:5290).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-18 05:02 JST
Intellia Therapeutics, Inc. (NTLA): A Bull Case Theory
Finviz2026-02-28 15:09:06
Absci Strengthens Clinical Leadership with Appointment of Ransi Somaratne, M.D., FACC, MBA as Chief Medical Officer
Finviz2026-03-03 13:03:53
Top Research Reports for Broadcom, AT&T & Vertex Pharmaceuticals
Finviz2026-03-03 23:06:27
Bank of America Securities Maintains $370 Price Target on Alphabet (GOOGL)
Finviz2026-03-05 00:45:40
Amazon, Google And Microsoft Keep Anthropic AI For Clients Despite Pentagon Risk Label
Finviz2026-03-07 04:51:44
AvePoint Announces General Availability of AgentPulse Command Center, with Multicloud Agentic AI Governance
Finviz2026-03-09 13:03:58
SailPoint redefines identity security with new adaptive identity innovations
Finviz2026-03-09 13:03:58
Septerna Highlights Pipeline Progress and Reports Fourth Quarter and Full Year 2025 Financial Results
Finviz2026-03-09 20:09:53
Vertex Pharmaceuticals announced positive interim results at week 36 from the phase III clinical trial (code-named Rainier) of its investigational drug Povetacicept for adult IgA nephropathy.
老虎证券2026-03-09 20:23:59
US Stock Movement | Vertex Pharmaceuticals (VRTX.US) surges after hours as late-stage trial of kidney drug povetacicept meets expected targets
老虎证券2026-03-10 00:29:37
CRISPR Therapeutics Announces Proposed Convertible Senior Notes Offering
Finviz2026-03-10 11:07:14
Here is Why CRISPR Therapeutics (CRSP) Appears so Good
Finviz2026-03-10 12:06:51
Vertex's New Kidney Drug Delivers Big Trial Win, Stock Jumps
Finviz2026-03-10 13:43:05
CRISPR Therapeutics Prices Upsized Convertible Senior Notes Offering
Finviz2026-03-11 11:03:53
Vertex Achieves Remarkable Growth, Sets New Industry Standard with ServiceTitan
Finviz2026-03-12 20:18:07
Vertex Now Available on Oracle Marketplace
Finviz2026-03-17 12:33:49
Cisco Reimagines Security for the Agentic Workforce
Finviz2026-03-23 12:03:49
Absci Reports Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results
Finviz2026-03-24 20:12:10
3D Systems Achieves Full-Scope EU MDR Certification, Accelerating European Launch of NextDent Jetted Denture Solution Targeted for Summer 2026
Finviz2026-03-25 12:21:46
Recently, FOTAI Pharma announced that its drugs Alyftrek® and Trikafta® have received label expansion approval from the U.S. Food and Drug Administration (FDA).
老虎证券2026-04-01 11:49:25
MIMEDX to Sponsor Leading Advanced Wound Care Conferences
Finviz2026-04-02 13:18:43
Vertex Advances AI-Powered Capabilities to Improve How Enterprises Execute Compliance
Finviz2026-04-07 12:03:44
Sam Altman's sky collapsed twice in one day
爱范儿2026-04-07 17:39:57
Biotechs Racing to Translate Longevity Science Into Real Therapies -- And One Microcap Company Is Producing An Anti-Aging Protein From Genetically Modified, Encapsulated Cells
Finviz2026-04-10 13:57:05
Amazon, Google And Microsoft Keep Anthropic AI For Clients Despite Pentagon Risk Label
Finviz2026-03-07 04:51:44
AvePoint Announces General Availability of AgentPulse Command Center, with Multicloud Agentic AI Governance
Finviz2026-03-09 13:03:58
SailPoint redefines identity security with new adaptive identity innovations
Finviz2026-03-09 13:03:58
Septerna Highlights Pipeline Progress and Reports Fourth Quarter and Full Year 2025 Financial Results
Finviz2026-03-09 20:09:53
Vertex Pharmaceuticals announced positive interim results at week 36 from the phase III clinical trial (code-named Rainier) of its investigational drug Povetacicept for adult IgA nephropathy.
老虎证券2026-03-09 20:23:59
US Stock Movement | Vertex Pharmaceuticals (VRTX.US) surges after hours as late-stage trial of kidney drug povetacicept meets expected targets
老虎证券2026-03-10 00:29:37
CRISPR Therapeutics Announces Proposed Convertible Senior Notes Offering
Finviz2026-03-10 11:07:14
Here is Why CRISPR Therapeutics (CRSP) Appears so Good
Finviz2026-03-10 12:06:51
Vertex's New Kidney Drug Delivers Big Trial Win, Stock Jumps
Finviz2026-03-10 13:43:05
CRISPR Therapeutics Prices Upsized Convertible Senior Notes Offering
Finviz2026-03-11 11:03:53
Vertex Achieves Remarkable Growth, Sets New Industry Standard with ServiceTitan
Finviz2026-03-12 20:18:07
Vertex Now Available on Oracle Marketplace
Finviz2026-03-17 12:33:49
Cisco Reimagines Security for the Agentic Workforce
Finviz2026-03-23 12:03:49
Absci Reports Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results
Finviz2026-03-24 20:12:10
3D Systems Achieves Full-Scope EU MDR Certification, Accelerating European Launch of NextDent Jetted Denture Solution Targeted for Summer 2026
Finviz2026-03-25 12:21:46
Recently, FOTAI Pharma announced that its drugs Alyftrek® and Trikafta® have received label expansion approval from the U.S. Food and Drug Administration (FDA).
老虎证券2026-04-01 11:49:25
MIMEDX to Sponsor Leading Advanced Wound Care Conferences
Finviz2026-04-02 13:18:43
Vertex Advances AI-Powered Capabilities to Improve How Enterprises Execute Compliance
Finviz2026-04-07 12:03:44
Sam Altman's sky collapsed twice in one day
爱范儿2026-04-07 17:39:57
Biotechs Racing to Translate Longevity Science Into Real Therapies -- And One Microcap Company Is Producing An Anti-Aging Protein From Genetically Modified, Encapsulated Cells
Finviz2026-04-10 13:57:05
TSE:5290 stock price change
On the last trading day, TSE:5290 stock closed at 2016.00 JPY, with a price change of -1.56% for the day.
Trade stock perpsTSE:5290 stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more